# Retrospective Analysis of the Experience With Larotrectinib in Patients With Solid Neoplasms With NTRK Fusion in Spain (SPAINTRK)

> **NCT06837090** · — · COMPLETED · sponsor: **Grupo Espanol de Tumores Neuroendocrinos** · enrollment: 20 (actual)

## Conditions studied

- Solid Neoplasms With NTRK Fusions

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06837090
- **Lead sponsor:** Grupo Espanol de Tumores Neuroendocrinos
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2025-02-11
- **Primary completion:** 2025-11-04
- **Final completion:** 2025-11-04
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2026-02-20

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06837090

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06837090, "Retrospective Analysis of the Experience With Larotrectinib in Patients With Solid Neoplasms With NTRK Fusion in Spain (SPAINTRK)". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06837090. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*